CAR-T Cell Therapy
Treatment using genetically modified T cells expressing a chimeric antigen receptor. Approved for B-cell lymphomas, ALL, and multiple myeloma; emerging for solid tumors.
No Hospitals found for this treatment modalitie.
Treatment using genetically modified T cells expressing a chimeric antigen receptor. Approved for B-cell lymphomas, ALL, and multiple myeloma; emerging for solid tumors.
No Hospitals found for this treatment modalitie.